Deputy Chief Executive at Association for Young People's Health
Discussed the underrepresentation of Gen Z in medical trials and its health implications.
How media typically covers Kirsty Blenkins
Referenced in coverage
Gen Z (ages 18-24) are significantly underrepresented in UK medical trials at 4.4% of participants despite comprising 8% of England's population, risking exposure to treatments not tested on their age group.
“Discussed the underrepresentation of Gen Z in medical trials and its health implications.”